BIOMAT Database Logo BIOMAT Database Logo

Pulmonary disease caused by scotochromogenic Mycobacteria. 1974

M K Tandon

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009164 Mycobacterium Infections Infections with bacteria of the genus MYCOBACTERIUM. Infections, Mycobacterium,Infection, Mycobacterium,Mycobacterium Infection
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

M K Tandon
Scotochromogenic mycobacteria.
June 1967, Bulletin of the International Union against Tuberculosis,
M K Tandon
Pulmonary disease caused by nontuberculous mycobacteria.
April 1990, Journal of thoracic imaging,
M K Tandon
Pulmonary disease caused by nontuberculous mycobacteria.
December 2012, Expert review of respiratory medicine,
M K Tandon
Pulmonary disease caused by nontuberculosis mycobacteria.
May 1980, The Medical clinics of North America,
M K Tandon
[Pulmonary disease caused by atypical mycobacteria].
November 1984, Medicina clinica,
M K Tandon
Pulmonary disease caused by photochromogenic mycobacteria.
May 1967, GP,
M K Tandon
Pulmonary Disease Caused by Non-Tuberculous Mycobacteria.
January 2016, Respiration; international review of thoracic diseases,
M K Tandon
Pulmonary disease caused by rapidly growing mycobacteria.
September 2002, Clinics in chest medicine,
M K Tandon
Classification of scotochromogenic mycobacteria.
March 1968, Japanese journal of microbiology,
M K Tandon
The role of scotochromogenic mycobacteria in human disease.
February 1963, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!